113 related articles for article (PubMed ID: 20051756)
1. An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab.
Kritikos K; Haritatos E; Tsigkos S; Gounari P; Skrapari I; Gounaris T; Sioula E
J Clin Rheumatol; 2010 Jan; 16(1):38-9. PubMed ID: 20051756
[TBL] [Abstract][Full Text] [Related]
2. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
Venizelos I; Tatsiou Z; Papathomas TG; Orazi A
Int J Infect Dis; 2009 Jul; 13(4):e169-72. PubMed ID: 19026580
[TBL] [Abstract][Full Text] [Related]
3. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.
Fabre S; Gibert C; Lechiche C; Dereure J; Jorgensen C; Sany J
Clin Exp Rheumatol; 2005; 23(6):891-2. PubMed ID: 16396712
[TBL] [Abstract][Full Text] [Related]
4. Fatal Salmonella enteritidis septicaemia in a rheumatoid arthritis patient treated with a TNF-alpha antagonist.
Rijkeboer A; Voskuyl A; Van Agtmael M
Scand J Infect Dis; 2007; 39(1):80-3. PubMed ID: 17366020
[TBL] [Abstract][Full Text] [Related]
5. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
6. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
Asano Y; Kano Y; Shiohara T
Acta Derm Venereol; 2008; 88(2):183-4. PubMed ID: 18311458
[No Abstract] [Full Text] [Related]
7. Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences.
Juzlova K; Votrubova J; Kacerovska D; Lukas M; Bortlik M; Rohacova H; Nohynkova E; Vojackova N; Fialova J; Hercogova J
Dermatol Ther; 2014; 27(3):131-4. PubMed ID: 24903470
[TBL] [Abstract][Full Text] [Related]
8. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.
Netea MG; Radstake T; Joosten LA; van der Meer JW; Barrera P; Kullberg BJ
Arthritis Rheum; 2003 Jul; 48(7):1853-7. PubMed ID: 12847679
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcal meningitis in a patient treated with infliximab.
Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
[TBL] [Abstract][Full Text] [Related]
10. Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel.
Shrestha RK; Stoller JK; Honari G; Procop GW; Gordon SM
Respir Care; 2004 Jun; 49(6):606-8. PubMed ID: 15165294
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use.
Mufti AH; Toye BW; Mckendry RR; Angel JB
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):233-8. PubMed ID: 16249064
[TBL] [Abstract][Full Text] [Related]
12. [Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis].
Baixauli Rubio A; Rodríguez Górriz E; Campos Fernández C; Calvo Catalá J; García Vicente S
An Med Interna; 2003 May; 20(5):276-7. PubMed ID: 12831311
[No Abstract] [Full Text] [Related]
13. Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy.
Kamili Qu; Menter A
J Drugs Dermatol; 2010 Jan; 9(1):57-60. PubMed ID: 20120426
[TBL] [Abstract][Full Text] [Related]
14. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
15. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.
Slifman NR; Gershon SK; Lee JH; Edwards ET; Braun MM
Arthritis Rheum; 2003 Feb; 48(2):319-24. PubMed ID: 12571839
[TBL] [Abstract][Full Text] [Related]
16. Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab.
Moltó A; Mateo L; Lloveras N; Olivé A; Minguez S
Joint Bone Spine; 2010 May; 77(3):271-3. PubMed ID: 20378385
[TBL] [Abstract][Full Text] [Related]
17. Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections.
Moiton MP; Richez C; Dumoulin C; Mehsen N; Dehais J; Schaeverbeke T
Clin Microbiol Infect; 2006 Dec; 12(12):1151-3. PubMed ID: 17121619
[TBL] [Abstract][Full Text] [Related]
18. Listeria meningitis associated with infliximab.
Bowie VL; Snella KA; Gopalachar AS; Bharadwaj P
Ann Pharmacother; 2004 Jan; 38(1):58-61. PubMed ID: 14742795
[TBL] [Abstract][Full Text] [Related]
19. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
